In a recent article published in Drug Discovery World, Glasgow has been highlighted as an important centre for drug discovery and development, following significant recent investment and the announcement of plans to construct a new Health Innovation Hub in the city.

As home to leading academic institutions, Glasgow is an attractive location for commercial businesses looking to be part of a thriving life sciences community where there is a real opportunity for collaborations and partnerships between industry, clinicians and academia.

Based at BioCity Scotland, BioAscent has been part of this growing community for the past ten years.

Click here to read the full article which includes comments from BioAscent's CEO, Paul Smith.